Prothrombin 20210A: F2 Targeted Analysis

F2 targeted analysis is a molecular test used to identify the common 20210G>A variant in the gene associated with Prothrombin.

Turnaround Time

1 week

CPT Code(s)

81240

Cost

$150

Genes

• Prothrombin thrombophilia

Two mutations within genes in the blood coagulation pathway that have been implicated as significant factors for thrombotic risk. These two defects, factor V Leiden and prothrombin 20210A, are responsible for over 60% of all cases of inherited thrombophilia. In addition to being significant risk factors for hypercoagulation, the mutations are frequently found in, but are not limited to, people of European descent. Carriers of the Leiden R506Q mutation have an 8 fold increased risk for venous thrombosis and homozygotes have a 91 fold increased risk. Specific acquired or environmental factors may dramatically increase this baseline risk. Approximately 5% percent of the Caucasian population carries the Factor V Leiden mutation. Three percent of the Caucasian population carries the prothrombin mutation. The molecular diagnosis of these mutations is done with the polymerase chain reaction and restriction endonuclease digestion or allele specific oligonucleotide amplification.

Molecular testing is useful to confirm the diagnosis and to identify the disease causing mutations within a family.

The preferred sample type is 3-5 ml of peripheral blood collected in an EDTA (purple top) tube. Extracted DNA, dried blood spots, and saliva are also accepted for this test. Saliva samples must be submitted in an approved saliva kit. Contact the lab to receive a saliva kit or to have one sent to your patient.

The specimen should be kept at room temperature and delivered via overnight shipping. If shipment is delayed by one or two days, the specimen should be refrigerated and shipped at room temperature. Do not freeze the specimen. Samples collected on Friday can be safely designated for Monday delivery.